Sylvie Crauste-Manciet

Prof. Dr. Sylvie Crauste-Manciet

ChemBioPharm, INSERM U1212, CNRS UMR 5320, Université de Bordeaux, 33076 Bordeaux, France
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
HRHéloïse Ragelle
Héloïse Ragelle
Sylvie Crauste-MancietSylvie Crauste-Manciet
Sylvie Crauste-Manciet
JSJohanne Seguin
Johanne Seguin
DBDenis Brossard
Denis Brossard
DSDaniel Scherman
Daniel Scherman
GCGuy G. Chabot
Guy G. Chabot

16 September 2003 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GNGeorges Nicolaos
Georges Nicolaos
Sylvie Crauste-MancietSylvie Crauste-Manciet
Sylvie Crauste-Manciet
RFRobert Farinotti
Robert Farinotti
DBDenis Brossard
Denis Brossard

26 August 2005 in Annals of Occupational Hygiene
Verified
Journal Article
Open access
PDF file
Sylvie Crauste-MancietSylvie Crauste-Manciet
Sylvie Crauste-Manciet
PSP. J. M. Sessink
P. J. M. Sessink
SFS. Ferrari
S. Ferrari
JJJ.-Y. Jomier
J.-Y. Jomier
DBD. Brossard
D. Brossard
Occupational exposure to cytotoxic drugs of hospital personnel involved in their preparation and administration is a major issue: ever since the introduction of protective measures in recent decades, the handling of these drugs has always been referred to as an occupational health hazard. Isolator technology was one of the protective equipments aimed at providing safe handling, but it has not yet been studied regarding contamination. The present study evaluates surface contamination with four cytotoxic drugs [cyclophosphamide (CP), ifosfamide (IF), 5 fluorouracil (5FU) and methotrexate (MTX)] by wipe sampling in two hospital pharmacies. Wipe samples were taken from work surfaces both located inside and outside the isolators. In addition, working gloves, the surface of infusion bags filled with 5FU or CP, and gloves used in simulation of drug administration were analyzed. Contamination was routinely found inside the isolators but rarely outside the isolators, indicating that the isolator technology is offering good protection of the cytotoxic drug handlers as well as the environment during preparation. On the other hand, contamination was found on the surfaces of infusion bags and gloves in contact with infusion bags filled with cytotoxic drugs. Consequently, personal protective equipment is still recommended during the manipulation and administration of the drugs because of potentially contaminated drug vials and final products.

19 April 2006 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
RLRichard Lenclen
Richard Lenclen
Sylvie Crauste-MancietSylvie Crauste-Manciet
Sylvie Crauste-Manciet
PNPhilippe Narcy
Philippe Narcy
SBSaida Boukhouna
Saida Boukhouna
AGAmélie Geffray
Amélie Geffray
DBDenis Brossard
Denis Brossard

13 November 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
GPGeoffrey Prévot
Geoffrey Prévot
FSFederico Soria
Federico Soria
MTMarie-Laure Thiolat
Marie-Laure Thiolat
JDJonathan Daniel
Jonathan Daniel
JVJean Baptiste Verlhac
Jean Baptiste Verlhac
BDBenjamin DEHAY
Benjamin DEHAY

1 February 2013 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
Sylvie Crauste-MancietSylvie Crauste-Manciet
Sylvie Crauste-Manciet
ESEstelle Sigward
Estelle Sigward
Nathalie MignetNathalie Mignet
Nathalie Mignet
PRPatrice Rat
Patrice Rat
MDMélody Dutot
Mélody Dutot
DBDenis Brossard
Denis Brossard
Three multiple water-in-oil-in-water (W/O/W) nanoemulsions have been designed for potential inclusion of either lipophilic or hydrophilic drugs using a two-step emulsification process exclusively based on low-energy self-emulsification. The W/O primary emulsion was constituted by a blend of oil (medium chain triglyceride), a mixture (7:3) of two surfactants, and a 10% water phase. The surfactants were a mixture of Polysorbate-85/Labrasol®, Polysorbate-85/ Cremophor® EL or glycerol/Polysorbate-85. The final W/O/W nanoemulsions were obtained by the addition of water, with a weight ratio nanoemulsion/water of 1:2. The multiple emulsion stability was found to increase from 24 hours to 2 and 6 months with Labrasol, glycerol, and Cremophor, respectively. Cytotoxicity was found for formulations including Labrasol and Cremophor EL. The concentration of emulsion inhibiting 50% cell viability (IC50) was determined using the alamarBlue® test, giving after 24 hours of incubation, IC50 = 10.2 mg/mL for the Labrasol formulation and IC50 = 11.8 mg/mL for the Cremophor EL formulation. Corresponding calculated IC50 values for surfactants were 0.51 mg/mL for Labrasol and 0.59 mg/mL for Cremophor EL. In both cases, cytotoxicity was due to an apoptotic mechanism, evidenced by chromatin condensation and P2X7 cell death receptor activation. The formulation including glycerol, investigated between 1 and 100 mg/mL concentration of nanoemulsion, did not affect cell viability. Moreover, neither chromatin condensation nor P2X7 activation was found between the 10 and 30 mg/mL final concentration of the emulsion. This last formulation would therefore be of major interest for further developments.